Search research articles
Contact Us
Filters
Showing results (651-660 of 771) with videos related to
Page
of 78
Sort By:
Translational Psychiatry
|
July 2, 2024
Factors underlying the neurofunctional domains of the Addictions Neuroclinical Assessment assessed by a standardized neurocognitive battery
Tommy Gunawan, Jeremy W Luk, Melanie L Schwandt, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
November 21, 2014
The corticotropin releasing hormone-1 (CRH1) receptor antagonist pexacerfont in alcohol dependence: a randomized controlled experimental medicine study
Laura E Kwako, Primavera A Spagnolo, Melanie L Schwandt, et al.
Clinical and Translational Science
|
July 11, 2026
A Multipart Phase 1 Study to Assess Safety and Pharmacokinetics of Ibuzatrelvir in Healthy Participants and Dose Selection for a Dose-Ranging Study
Ravi Shankar P Singh, Sima S Toussi, Frances Hackman, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
June 5, 2002
Goodpasture's disease in the absence of circulating anti-glomerular basement membrane antibodies as detected by standard techniques
Alan D Salama, Tammy Dougan, Jeremy B Levy, et al.
American Journal of Medical Genetics
|
November 1, 1993
Genetic contributions to quantitative lipoprotein traits associated with coronary artery disease: analysis of a large pedigree from the Bogalusa Heart Study
I M Heiba, C A DeMeester, Y R Xia, et al.
AIDS (London, England)
|
May 10, 2014
Epicardial fat is associated with duration of antiretroviral therapy and coronary atherosclerosis
Michael Brener, Kerunne Ketlogetswe, Matthew Budoff, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro
|
July 23, 2019
NRF2 activates a partial epithelial-mesenchymal transition and is maximally present in a hybrid epithelial/mesenchymal phenotype
Federico Bocci, Satyendra C Tripathi, Samuel A Vilchez Mercedes, et al.
Journal of Hypertension
|
July 4, 2020
Heart failure and renal outcomes according to baseline and achieved blood pressure in patients with type 2 diabetes: results from EMPA-REG OUTCOME
Michael Böhm, David Fitchett, Anne Pernille Ofstad, et al.
European Heart Journal
|
October 12, 2017
Effects of empagliflozin on risk for cardiovascular death and heart failure hospitalization across the spectrum of heart failure risk in the EMPA-REG OUTCOME® trial
David Fitchett, Javed Butler, Philippe van de Borne, et al.
Diabetes Care
|
June 10, 2019
Exploring Patient Preferences for Adjunct-to-Insulin Therapy in Type 1 Diabetes
Bruce A Perkins, Julio Rosenstock, Jay S Skyler, et al.
Page
of 78
Search research articles
Search
Showing results (651-660 of 771) with videos related to
Sort By:
Page
of 78
Translational Psychiatry
|
July 2, 2024
Factors underlying the neurofunctional domains of the Addictions Neuroclinical Assessment assessed by a standardized neurocognitive battery
Tommy Gunawan, Jeremy W Luk, Melanie L Schwandt, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
November 21, 2014
The corticotropin releasing hormone-1 (CRH1) receptor antagonist pexacerfont in alcohol dependence: a randomized controlled experimental medicine study
Laura E Kwako, Primavera A Spagnolo, Melanie L Schwandt, et al.
Clinical and Translational Science
|
July 11, 2026
A Multipart Phase 1 Study to Assess Safety and Pharmacokinetics of Ibuzatrelvir in Healthy Participants and Dose Selection for a Dose-Ranging Study
Ravi Shankar P Singh, Sima S Toussi, Frances Hackman, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
June 5, 2002
Goodpasture's disease in the absence of circulating anti-glomerular basement membrane antibodies as detected by standard techniques
Alan D Salama, Tammy Dougan, Jeremy B Levy, et al.
American Journal of Medical Genetics
|
November 1, 1993
Genetic contributions to quantitative lipoprotein traits associated with coronary artery disease: analysis of a large pedigree from the Bogalusa Heart Study
I M Heiba, C A DeMeester, Y R Xia, et al.
AIDS (London, England)
|
May 10, 2014
Epicardial fat is associated with duration of antiretroviral therapy and coronary atherosclerosis
Michael Brener, Kerunne Ketlogetswe, Matthew Budoff, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro
|
July 23, 2019
NRF2 activates a partial epithelial-mesenchymal transition and is maximally present in a hybrid epithelial/mesenchymal phenotype
Federico Bocci, Satyendra C Tripathi, Samuel A Vilchez Mercedes, et al.
Journal of Hypertension
|
July 4, 2020
Heart failure and renal outcomes according to baseline and achieved blood pressure in patients with type 2 diabetes: results from EMPA-REG OUTCOME
Michael Böhm, David Fitchett, Anne Pernille Ofstad, et al.
European Heart Journal
|
October 12, 2017
Effects of empagliflozin on risk for cardiovascular death and heart failure hospitalization across the spectrum of heart failure risk in the EMPA-REG OUTCOME® trial
David Fitchett, Javed Butler, Philippe van de Borne, et al.
Diabetes Care
|
June 10, 2019
Exploring Patient Preferences for Adjunct-to-Insulin Therapy in Type 1 Diabetes
Bruce A Perkins, Julio Rosenstock, Jay S Skyler, et al.
Page
of 78